Equivalent Lung Dose and Systemic Exposure of Budesonide/Formoterol Combination via Easyhaler and Turbuhaler

Background: Easyhaler(®) device-metered dry powder inhaler containing budesonide and formoterol fumarate dihydrate (hereafter formoterol) for the treatment of asthma and chronic obstructive pulmonary disease has been developed. The current approvals of the product in Europe were based on several pha...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Aerosol Med Pulm Drug Deliv
Egile Nagusiak: Lähelmä, Satu, Sairanen, Ulla, Haikarainen, Jussi, Korhonen, Jani, Vahteristo, Mikko, Fuhr, Rainard, Kirjavainen, Merja
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Mary Ann Liebert, Inc. 2015
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4688463/
https://ncbi.nlm.nih.gov/pubmed/25757188
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/jamp.2014.1195
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak